How does metformin help for PCOS?

J Clin Endocrinol metab. 2005 Aug;90(8):4593-8.

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.Harborne LR,Sattar N,Norman JE,Fleming R.

University Department of Obstetrics and Gynecology, Level 3 QEB, Royal Infirmary, Glasgow, United Kingdom G31 2ER.

Context:

Metformin treatment of women with polycystic ovary syndrome (PCOS) is widespread, as determined by studies with diverse patient populations. No comparative examination of weight changes or metabolite responses to different doses has been reported.

Objectives:

The aim of this study was to determine whether different doses of metformin (1500 or 2550 mg/d) would have different effects on body weight, circulating hormones, markers of inflammation, and lipid profiles.

Design:

The study included prospective cohorts randomized to two doses of metformin.

Setting:

The study was performed at a university teaching hospital with patients from gynecology/endocrinology clinics.

Patients:

The patients studied were obese (body mass index, 30 to<37 kg/m2; n = 42) and morbidly obese (body mass index, > or =37 kg/m2; n = 41) women with PCOS.

Intervention:

Patients were randomized to two doses of metformin, and parameters were assessed after 4 and 8 months.

Settings, Design and Main Outcome Measures:

The main outcome measures were changes in body mass, circulating hormones, markers of inflammation, and lipid profiles.

Results:

Intention to treat analyses showed significant weight loss in both dose groups. Only the obese subgroup showed a dose relationship (1.5 and 3.6 kg in 1500- and 2550-mg groups, respectively; P = 0.04). The morbidly obese group showed similar reductions (3.9 and 3.8 kg) in both groups. Suppression of androstenedione was significant with both metformin doses, but there was no clear dose relationship. Generally, beneficial changes in lipid profiles were not related to dose.

Conclusion:

Weight loss is a feature of protracted metformin therapy in obese women with PCOS, with greater weight reduction potentially achievable with higher doses. Additional studies are required to determine whether other aspects of the disorder may benefit from the higher dose of metformin.

See Also:

PCOS - Polycystic Ovary Syndrome

Do you have an unanswered women's health question?

Please let us have your general question on our NEW FORUM / MESSAGE BOARDS facility and we will try to answer it for you. I am sure that you will appreciate that we cannot offer advice on the management of an individual's specific problem.

 

 

Please subscribe to receive our FREE women's health newsletter. STAY UP TO DATE on the important issues affecting YOUR HEALTH.
First Name:
Family Name:
Email:
Profession:
Country:
Age:

DISCLAIMER

The aim of this web site is to provide a general guide and it is not intended as a substitute for a consultation with an appropriate specialist in respect of individual care and treatment.

Thank you for your visiting us at 2womenshealth.com.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.

I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.